Back to discover
Drug

Linoleic Acid

In clinical development
Emerging researchLate-stage development
Also known as (9Z,12Z)-Octadecadienoic acid, 9-cis,12-cis-Octadecadienoic acid, 9Z,12Z-octadecadienoic acid, Encora Capsule+10 more

(9Z,12Z)-Octadecadienoic acid, 9-cis,12-cis-Octadecadienoic acid, 9Z,12Z-octadecadienoic acid, Encora Capsule, LA, acide cis-linoléique, acide linoléique, cis,cis-linoleic acid, ácido linoleico, Linolic acid, (Z,Z)-9,12-octadecadienoic acid, C18:2 9c, 12c omega6 todos cis-9,12-octadienoico, all-cis-9,12-octadecadienoic acid, cis,cis-9,12-octadecadienoic acid.

RxNorm6400ChEMBLCHEMBL267476UNII9KJL21T0QJ
2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Linoleic Acid
Aliases & brands
(9Z,12Z)-Octadecadienoic acid9-cis,12-cis-Octadecadienoic acid9Z,12Z-octadecadienoic acidEncora CapsuleLAacide cis-linoléiqueacide linoléiquecis,cis-linoleic acidácido linoleicoLinolic acid(Z,Z)-9,12-octadecadienoic acidC18:2 9c, 12c omega6 todos cis-9,12-octadienoicoall-cis-9,12-octadecadienoic acidcis,cis-9,12-octadecadienoic acid
RxNorm CUI
6400
ChEMBL ID
CHEMBL267476
UNII
9KJL21T0QJ

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
LATEST COMPLETION 2022
1
Late-stage (III+)
1
Completed
PHASE DISTRIBUTIONn = 1
Phase 41

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of AICDs and Pacemakers in Pediatric Patients

CompletedPH IVThe University of Texas Health Science Center, Houstonn=192022

Recent completions

Trials that read out recently, adding to the completed evidence base.

Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of AICDs and Pacemakers in Pediatric Patients

CompletedPH IVThe University of Texas Health Science Center, Houstonn=192022

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20192024
Major research themes4
Colitis1Gastrointestinal Microbiome1Inflammatory Bowel Diseases1Periodontitis1
Journals, researchers & institutions
Top journals
  • Nature communications2
Leading researchers
  • Arita M1
  • Drucker DJ1
  • Du J1
  • Fu J1
  • Guo L1
  • Ichimura A1
  • Igarashi M1
  • Irie J1
Leading institutions
free-text, unnormalised
  • Department of Orthodontics School of Stomatology1
  • Graduate School of Agriculture1
  • Graduate School of Medicine1
  • Graduate School of Pharmaceutical Sciences1
  • Keio University1
  • Laboratory for Metabolomics1

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas
Inflammation2
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials